Harry Sloan, Director at Ginkgo Bioworks Holdings, Inc. (DNA), bought 350,000 shares at $1.28 ($448K) on 2023-05-18, disclosed to the SEC on 2023-05-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| STRZ | BUY | 2025-08-21 | $285K | — | Filing → |
| DKNG | SELL | 2024-06-14 | $9.5M | — | Filing → |
| DNA | BUY | 2024-05-14 | $542K | — | Filing → |